Activating Mutations of Gsα in Kidney Cancer

Journal of Urology

Volumn 176, Issue 3, 2006, Pages 891-895

  Kalfa, Nicolas ^a,c   Lumbroso, Serge ^a,c   Boulle, Nathalie ^c   Guiter, Jacques ^b,c   Soustelle, Laurent ^c,d   Costa, Pierre ^c,d   Chapuis, Heliette ^c,d   Baldet, Pierre ^b,c   Sultan, Charles ^a,b,c  

^a Institut National de la Santé et de la Recherche Médicale U540   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

Author keywords

carcinoma; genetics; Gs; GTP binding protein alpha subunits; kidney; mutation; renal cell

Indexed keywords

ARGININE; CYSTEINE; HISTIDINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA DETERMINATION; ENZYMATIC ASSAY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; KIDNEY CARCINOMA; LASER MICRODISSECTION; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MUTATION;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION;

EID: 33746514634     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.04.023     Document Type: Article

References (21)

1. Lam J.S., Shvarts O., Leppert J.T., Figlin R.A., and Belldegrun A.S. Renal cell carcinoma 2005. new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173 (2005) 1853
2. Linehan W.M., Walther M.M., and Zbar B. The genetic basis of cancer of the kidney. J Urol 170 (2003) 2163
3. Vallar L., Spada A., and Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330 (1987) 566
4. O'Sullivan C., Barton C.M., Staddon S.L., Brown C.L., and Lemoine N.R. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4 (1991) 345
5. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., and Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325 (1991) 1688
6. Plisov S.Y., Ivanov S.V., Yoshino K., Dove L.F., Plisova T.M., Higinbotham K.G., et al. Mesenchymal-epithelial transition in the developing metanephric kidney. gene expression study by differential display. Genesis 27 (2000) 22
7. Lumbroso S., Paris F., and Sultan C. Activating Gsalpha mutations. analysis of 113 patients with signs of McCune-Albright syndrome-a European Collaborative Study. J Clin Endocrinol Metab 89 (2004) 2107
8. Candeliere G.A., Roughley P.J., and Glorieux F.H. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 21 (1997) 201
9. Schutze K., and Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotech 16 (1998) 737
10. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 (1993) 1317
11. Bui M.H., Seligson D., Han K.R., Pantuck A.J., Dorey F.J., Huang Y., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma. implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802
12. Faure M., Voyno-Yasenetskaya T.A., and Bourne H.R. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269 (1994) 7851
13. Chien J., Wong E., Nikes E., Noble M.J., Pantazis C.G., and Shah G.V. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)- mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells. Oncogene 18 (1999) 3376
14. Regnauld K., Nguyen Q.D., Vakaet L., Bruyneel E., Launay J.M., Endo T., et al. G-protein alpha(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells. Oncogene 21 (2002) 4020
15. Takahashi M., Yang X.J., Sugimura J., Backdahl J., Tretiakova M., Qian C.N., et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22 (2003) 6810
16. Furuya M., Nishiyama M., Kimura S., Backdahl J., Tretiakova M., Qian C.N., et al. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J Pathol 203 (2004) 551
17. Deguchi M., Shiina H., Igawa M., Kaneuchi M., Nakajima K., and Dahiya R. DNA mismatch repair genes in renal cell carcinoma. J Urol 169 (2003) 2365
18. Hohenegger M., Waldhoer M., Beindl W., Boing B., Kreimeyer A., Nickel P., et al. Gsalpha-selective G protein antagonists. Proc Natl Acad Sci USA 95 (1998) 346
19. Zheng B., Ma Y.C., Ostrom R.S., Lavoie C., Gill G.N., Insel P.A., et al. RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science 294 (2001) 1939
20. Beeler J.A., Yan S.Z., Bykov S., Murza A., Asher S., and Tang W.J. A soluble C1b protein and its regulation of soluble type 7 adenylyl cyclase. Biochemistry 43 (2004) 15463
21. Chapman N.R., Smyrnias I., Anumba D.O., Europe-Finner G.N., and Robson S.C. Expression of the GTP-binding protein (Galphas) is repressed by the nuclear factor kappaB RelA subunit in human myometrium. Endocrinology 146 (2005) 4994